Sort by
Refine Your Search
-
Listed
-
Field
-
) for the identification and prioritization of novel biomarkers and drug targets Design and perform biomedical experiments to advance therapeutic discovery, including developing and optimizing cell-based and biochemical
-
satisfactory performance and consideration for tenure before the expiry of a second three-year fixed-term contract. Applicants should possess a Ph.D. degree or equivalent in Surgery or related disciplines, with
-
majors (Global and Area Studies, Japanese Studies, and Korean Studies) and 13 language programmes (Arabic, French, German, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Swedish, Thai
-
Deadline 9 Apr 2026 - 00:00 (UTC) Country Hong Kong Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related
-
Deadline 9 Apr 2026 - 00:00 (UTC) Country Hong Kong Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related
-
(R1) Application Deadline 30 Mar 2026 - 00:00 (UTC) Country Hong Kong Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
three-year fixed-term basis, with the possibility of renewal and with consideration for tenure before the expiry of a second three-year fixed-term contract, subject to satisfactory performance and funding
-
Apr 2026 - 00:00 (UTC) Country Hong Kong Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to
-
years of full-time teaching experience at the tertiary level. Past teaching should include introductory to intermediate-level undergraduate courses in computational methods, e.g., programming, data
-
Studies (MAHKCS) in the School of Chinese (Ref.: 534140), to commence on July 1, 2026, on a two-year fixed-term basis, with the possibility of renewal subject to satisfactory performance and availability